Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
71,153,743
-
Total 13F shares
-
50,065,423
-
Share change
-
+624,623
-
Total reported value
-
$376,991,240
-
Put/Call ratio
-
0.43%
-
Price per share
-
$7.53
-
Number of holders
-
170
-
Value change
-
+$2,353,854
-
Number of buys
-
87
-
Number of sells
-
79
Institutional Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q1 2024
As of 31 Mar 2024,
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) was held by
170 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,065,423 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Bank of New York Mellon Corp, Daventry Group, LP, Impax Asset Management Group plc, PRIMECAP MANAGEMENT CO/CA/, Point72 Asset Management, L.P., DIMENSIONAL FUND ADVISORS LP, and STATE STREET CORP.
This page lists
170
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.